{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:15:08Z","timestamp":1783116908710,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdermsci.2021.09.001","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:23:06Z","timestamp":1630668186000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H\/HeJ mouse model"],"prefix":"10.1016","volume":"104","author":[{"given":"Kei","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Uratsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2021.09.001_bib0005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.04.035","article-title":"Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review","volume":"75","author":"Liu","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","article-title":"Alopecia areata. A.N. Evaluation of 736 patients","volume":"88","author":"Muller","year":"1963","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000017935","article-title":"Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases","volume":"196","author":"Pericin","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0030","first-page":"1","article-title":"Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata","author":"Manimaran","year":"2020","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines--part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107626","article-title":"Pulse corticosteroid therapy for alopecia areata: study of 139 patients","volume":"215","author":"Nakajima","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13555-020-00370-2","article-title":"Cyclosporine with and without systemic corticosteroids in treatment of Alopecia Areata: a systematic review","volume":"10","author":"Nowaczyk","year":"2020","journal-title":"Dermatol. Ther. (Heidelb)."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia Areata: a Comprehensive Review of Pathogenesis and Management","volume":"54","author":"Tr\u00fceb","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/1346-8138.13933","article-title":"Management of alopecia areata: updates and algorithmic approach","volume":"44","author":"Lee","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0070","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","volume":"66","author":"Paus","year":"1993","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jid.2016.04.004","article-title":"Identification of Autoantigen Epitopes in Alopecia Areata","volume":"136","author":"Wang","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jdermsci.2013.07.014","article-title":"Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology","volume":"72","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0095","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of Alopecia Areata to C3H\/HeJ mice using cultured lymph node-derived cells","volume":"135","author":"Wang","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-0716-0648-3_10","article-title":"Nonsurgical induction of alopecia areata in C3H\/HeJ mice via adoptive transfer of cultured lymphoid cells","volume":"2154","author":"Wang","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1523-1747.1999.00640.x","article-title":"Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H\/HeJ mice","volume":"113","author":"Freyschmidt-Paul","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0115","first-page":"369","article-title":"Patterns of lymphatic drainage in the adult laboratory rat","volume":"109","author":"Tilney","year":"1971","journal-title":"J. Anat."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0120","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/00015555642630","article-title":"Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata","volume":"64","author":"Perret","year":"1984","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0130","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0140","article-title":"Interferon-gamma serum level and immunohistochemical expression of CD8 cells in tissue biopsies in patients with alopecia areata in correlation with trichoscopic findings","volume":"33","author":"Agamia","year":"2020","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0145","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits t cell migration into the skin and prevents development of alopecia areata","volume":"197","author":"Dai","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","article-title":"T cells and the skin: from protective immunity to inflammatory skin disorders","volume":"19","author":"Ho","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0160","article-title":"A transcriptomic map of murine and human alopecia areata","volume":"5","author":"Borcherding","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygeno.2010.05.002","article-title":"Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures","volume":"96","author":"Subramanya","year":"2010","journal-title":"Genomics."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0175","first-page":"187","article-title":"Interleukin-12: a cytokine with therapeutic potential in oncology and infectious diseases","volume":"1","author":"Gately","year":"1994","journal-title":"Ther. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0185","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/jid.2012.134","article-title":"Capturing the finer points of gene expression in psoriasis: beaming in on the CCL19\/CCR7 axis","volume":"132","author":"Ritti\u00e9","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/1523-1747.ep12470166","article-title":"Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy","volume":"88","author":"Br\u00f6cker","year":"1987","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0200","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/pr100422u","article-title":"Trichohyalin is a potential major autoantigen in human alopecia areata","volume":"9","author":"Leung","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0205","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1189\/jlb.0413196","article-title":"Tolerance induction by hair-specific keratins in murine alopecia areata","volume":"94","author":"Erb","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jdermsci.2021.09.001_bib0210","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2011.10597.x","article-title":"Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata","volume":"165","author":"Kemp","year":"2011","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181121002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:52:12Z","timestamp":1760331132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181121002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0923181121002024"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.09.001","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H\/HeJ mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}